Allotment Status
Registrar: MUFG Intime India
Issue price
₹159
Listing price
₹165.901
Last GMP (₹)
₹9
GMP estimate
+5.66%
Actual listing gain
+4.34%
Return per lot
+₹648.656
GMP vs listing performance
GMP pointed to +5.66% but the stock listed at +4.34% — 1.3% lower than estimated.
Listing gain calculator
Estimate profit or loss based on actual listing performance
Based on issue price ₹159 × 94 shares per lot. Listing price ₹166. Excludes taxes, DP charges, and selling costs.
Listing results from exchange debut data where recorded. See GMP accuracy report · How we track this
LEAP India IPO listed on 14 Aug 2026 at an issue price of ₹159, gained 4.3% on listing day. It listed near its issue price. The issue was subscribed 8.82x overall.
LEAP India is a recently listed Mainboard IPO in India, raising ₹2480.00 Cr, with shares offered around ₹159. The stock has listed with a +4.3% debut move versus the issue price. For business fundamentals, revenue trends, and use of proceeds, read the RHP on SEBI or NSE/BSE — we summarise market metrics, not audited financials.
GMP and subscription figures are unofficial market data, refreshed twice daily for active IPOs. Last updated 11 Aug 2026, 05:24 pm IST. How we source data · Disclaimer
FAQ
LEAP India's IPO has been listed on the BSE at ₹166, a 4.4% premium to its issue price of ₹159. The stock also listed on the NSE at ₹165.90, up 4.3% from the issue price. The listing took place amid a weak overall stock market sentiment.
Read full storyLEAP India IPO allotment is expected soon, with the company's shares currently trading at a grey market premium (GMP) of ₹13. The final subscription status for the IPO has been reported, and investors can check their application status online. The allotment date is eagerly awaited by investors who participated in the IPO.
Read full storyLEAP India's IPO has entered its third day, with the subscription status and Grey Market Premium (GMP) under review. The company's shares are currently trading at a premium of ₹13 in the grey market. The IPO's progress and GMP will be closely watched by investors as it nears its closing date.
Read full story